Finance

Beta
Lists
ACTU:NASDAQ
Actuate Therapeutics Inc
$1.37
+11.37%
(+0.14) 1D
Jul 10, 1:45:38 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACTU...
Open
$1.24
High
$1.37
Low
$1.22
Mkt. cap
32.78M
Avg. vol.
195.67K
Volume
130.91K
52-wk high
$9.22
52-wk low
$1.16
EPS
-$0.99
Shares outstanding
23.93M
No. of employees
12
Open
$1.24
High
$1.37
Low
$1.22
Mkt. cap
32.78M
Avg. vol.
195.67K
Volume
130.91K
52-wk high
$9.22
52-wk low
$1.16
EPS
-$0.99
Shares outstanding
23.93M
No. of employees
12
News stories
From sources across the web
About Actuate Therapeutics Inc
CEO-
Employees12
Founded2015
HeadquartersFort Worth, Texas, United States
SectorBiotechnology
Websiteactuatetherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ACTU in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACTU in the last 3 months.
Highest
Current $1.37
$15.00 (+994.97%)
Average
$10.67 (+678.89%)
Lowest
$5.00 (+264.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$15.00
+995%
06/10/2026
Christopher Liu
Lucid Capital
Buy
Maintained
$5.00
+265%
05/18/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$12.00
+776%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.76M
2.18M
2.13M
2.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.20M
3.29M
2.56M
3.14M
Operating expense
5.97M
5.47M
4.69M
5.71M
Total operating expenses
5.97M
5.47M
4.69M
5.71M
Operating income
-5.97M
-5.47M
-4.69M
-5.71M
Other non operating income
-
-
-
-
EBT including unusual items
-5.95M
-5.41M
-4.55M
-5.63M
EBT excluding unusual items
-5.95M
-5.41M
-4.55M
-5.63M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.95M
-5.41M
-4.55M
-5.63M
Net profit margin
-
-
-
-
Earnings per share
-0.30
-0.25
-0.18
-0.24
Interest and investment income
24.53K
69.97K
139.58K
85.27K
Interest expense
-5.06K
-5.06K
-5.06K
-5.06K
Net interest expenses
19.47K
64.91K
134.52K
80.21K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer